ArticleACS medicinal chemistry letters2025

Novel 5‑[2,7-Diazaspiro[3.5]nonan-7-yl]-5-[4-phenoxyphenyl]hexahydropyrimidine-2,4,6-trione Derivatives as MMP9 Inhibitors for Treating Ocular Surface Diseases, in Particular Dry Eye Disease.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.